| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| ONL-1204 | ONL-1204 | Phase 2 Clinical | Onl Therapeutics | Glaucoma, Open-Angle; Retinal Detachment; Geographic Atrophy | Details |
| English Name | Research Code | Highest Development Stage | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indication | Clinical Trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Kanglaite | Approved | Zhejiang Kanglaite Pharmaceutical Co Ltd | Kanglaite | Mainland China | Liver Neoplasms; Carcinoma, Non-Small-Cell Lung | Zhejiang Kanglaite Pharmaceutical Co Ltd | 1997-01-01 | Liver Neoplasms; Solid tumours; Neoplasms; Prostatic Neoplasms; Carcinoma, Non-Small-Cell Lung | Details |

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521
주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호



